Learning Objectives

As a result of attending this session, participants will be able to:

1. Understand the indications for cytoreductive nephrectomy in advanced kidney cancer
2. Review the current evidence supporting and against nephrectomy in advanced kidney cancer
3. Understand the sequencing of therapies for advanced kidney cancer